InnoCare Pharma
ISIN KYG4783B1032
|WKN A2PVC2
Overview
Description
InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals China
Financials
Key metrics
| Market capitalisation, EUR | 797.93 m |
| EPS, EUR | -0.06 |
| P/B ratio | 1.04 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 95.15 m |
| Net income, EUR | -82.42 m |
| Profit margin | -86.61% |
What ETF is InnoCare Pharma in?
There are 15 ETFs which contain InnoCare Pharma. All of these ETFs are listed in the table below. The ETF with the largest weighting of InnoCare Pharma is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| iShares MSCI Emerging Markets Small Cap UCITS ETF | 0.03% | Equity Emerging Markets Small Cap | 2,066 | 0.74% | 340 | +13.86% | A0RGER | IE00B3F81G20 |
| UBS ETF (LU) Solactive China Technology UCITS ETF (USD) A-acc | 0.13% | Equity China Technology Innovation | 99 | 0.47% | 14 | -20.36% | A2QJ9G | LU2265794276 |
| SPDR MSCI Emerging Markets Small Cap UCITS ETF | 0.02% | Equity Emerging Markets Small Cap | 2,034 | 0.55% | 345 | +15.97% | A1JJTF | IE00B48X4842 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 5,810 | 0.24% | 286 | +18.75% | A2QL8V | IE00BNG8L385 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing | 0.01% | Equity Emerging Markets Social/Environmental | 3,526 | 0.24% | 17 | +8.63% | A3DJRD | IE0001VXZTV7 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity Emerging Markets Social/Environmental | 3,526 | 0.24% | 22 | +8.77% | A3DJRC | IE000KPJJWM6 |
| iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF | 0.05% | Equity Asia Pacific Small Cap | 1,250 | 0.74% | 56 | +2.98% | A0Q1YZ | IE00B2QWDR12 |
| Fidelity Sustainable Research Enhanced Emerging Markets Equity UCITS ETF Acc | 0.02% | Equity Emerging Markets Social/Environmental | 276 | 0.30% | 1,386 | +8.63% | A2P2QA | IE00BLRPN388 |
| L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.38% | Equity World Social/Environmental Innovation | 358 | 0.60% | 4 | +1.07% | A3DHPA | IE000VTOHNZ0 |
| iShares Core MSCI Emerging Markets IMI UCITS ETF | 0.00% | Equity Emerging Markets | 3,103 | 0.18% | 1,184 | +9.93% | A2JDYF | IE00BD45KH83 |
| UBS ETF (LU) Solactive China Technology UCITS ETF (hedged to EUR) A-acc | 0.13% | Equity China Technology Innovation | 99 | 0.50% | 6 | -22.13% | A2QJ9P | LU2265794946 |
| iShares Core MSCI Emerging Markets IMI UCITS ETF (Acc) | 0.00% | Equity Emerging Markets | 3,103 | 0.18% | 18,952 | +9.84% | A111X9 | IE00BKM4GZ66 |
| HSBC MSCI Emerging Markets Small Cap ESG UCITS ETF USD (Acc) | 0.05% | Equity Emerging Markets Small Cap | 910 | 0.35% | 46 | +6.97% | A3DUNU | IE000W080FK3 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity World Social/Environmental | 5,810 | 0.24% | 369 | +18.82% | A2QL8U | IE00BNG8L278 |
| L&G Pharma Breakthrough UCITS ETF | 2.03% | Equity World Health Care Innovation | 43 | 0.49% | 17 | -2.90% | A2H9XR | IE00BF0H7608 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.